Last10K.com

Domain Registration Corp (1080908) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, December 31, 2008

Biopharm Asia, Inc.

HISTORY TOOLS
CIK: 1080908

View differences made from one year to another to evaluate Biopharm Asia, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biopharm Asia, Inc..

Continue

Assess how Biopharm Asia, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biopharm Asia, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2009 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Biopharm Asia, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
CIK: 1080908
Form Type: 10-K Annual Report
Accession Number: 0001193805-09-000801
Submitted to the SEC: Wed Apr 15 2009 5:08:23 PM EST
Accepted by the SEC: Wed Apr 15 2009
Period: Wednesday, December 31, 2008
Industry: Pharmaceutical Preparations

External Resources:
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/1080908/0001193805-09-000801.htm